Cargando…
Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction
Multiple myeloma (MM) remains a lethal hematologic cancer characterized by the expansion of transformed plasma cells within the permissive bone marrow (BM) milieu. The emergence of relapsed and/or refractory MM (RRMM) is provoked through clonal evolution of malignant plasma cells that harbor genomic...
Autores principales: | Rana, Priyanka S., Soler, David C., Kort, Jeries, Driscoll, James J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790996/ https://www.ncbi.nlm.nih.gov/pubmed/36578789 http://dx.doi.org/10.3389/fcell.2022.1059715 |
Ejemplares similares
-
Road testing new CAR design strategies in multiple myeloma
por: Rana, Priyanka S., et al.
Publicado: (2022) -
Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma
por: Bose, Mukulika, et al.
Publicado: (2022) -
The Roles of TGF-β Signaling in Cerebrovascular Diseases
por: Zhang, Yizhe, et al.
Publicado: (2020) -
Diverse Role of TGF-β in Kidney Disease
por: Gu, Yue-Yu, et al.
Publicado: (2020) -
TGF-β Signaling and Resistance to Cancer Therapy
por: Zhang, Maoduo, et al.
Publicado: (2021)